title: Drosophila melanogaster: a new model to study cisplatin-induced neurotoxicity.
abstract: Platinum-based compounds are widely used and effective chemotherapeutic agents; however, sensory peripheral neuropathy is a dose-limiting and long term side effect for 20-30% of patients. A critical question is whether the mechanisms of cell death underlying clinical efficacy can be separated from the effects on neurons in order to develop strategies that prevent platinum-induced neuropathy. In rodent dorsal root ganglion neurons (DRG), cisplatin has been shown to bind and damage neuronal DNA, inducing apoptosis; however genetic manipulation in order to study mechanisms of this phenomenon in the rodent model system is costly and time-consuming. Drosophila melanogaster are commonly used to study neurological disorders, have DNA damage-apoptosis mechanisms homologous to mammalian systems, and have readily-available, inexpensive tools for rapid genetic manipulation. We therefore sought to develop adult Drosophila as a new model to study cisplatin-induced neurotoxicity. Adult Drosophila were exposed to 10, 25, 50, 100, 200 and 400 μg/ml cisplatin for 3 days and observed for fly survival and geotactic climbing behavior, cisplatin-DNA binding and cellular apoptosis. On day 3, 50 μg/ml cisplatin reduced the number of flies able to climb above 2 cm to 43% while fly survival was maintained at 92%. 100% lethality was observed at 400 μg/ml cisplatin. Whole fly platinum-genomic DNA adducts were measured and found to be comparable to adduct levels previously measured in rat DRG neurons. Brain, ovaries, kidney and heart harvested from cisplatin treated flies were stained for active caspase 3. Apoptosis was found in ovaries and brain but not in heart and kidney. Brain apoptosis was confirmed by transmission electron microscopy. Expression of the anti-apoptotic baculoviral protein, p35, in neurons using the GAL4-UAS system prevented cisplatin-induced apoptosis in the brain and restored climbing behavior. In conclusion, cisplatin-induced behavioral and apoptotic changes in Drosophila resemble those seen in mammals. Furthermore, the use of lethality and climbing assays combined with powerful gene manipulation, make Drosophila a suitable model to study mechanisms of cisplatin neurotoxicity.
authors.affiliation: Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Jewel L
authors.initials: JL
authors.lastname: Podratz
authors.forename: Nathan P
authors.initials: NP
authors.lastname: Staff
authors.forename: Dara
authors.initials: D
authors.lastname: Froemel
authors.forename: Anna
authors.initials: A
authors.lastname: Wallner
authors.forename: Florian
authors.initials: F
authors.lastname: Wabnig
authors.forename: Allan J
authors.initials: AJ
authors.lastname: Bieber
authors.forename: Amy
authors.initials: A
authors.lastname: Tang
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Windebank
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002945:Cisplatin / Q000633:toxicity*; D004195:Disease Models, Animal; D004331:Drosophila melanogaster / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D005260:Female; D009410:Nerve Degeneration / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000821:virology; D009498:Neurotoxins / Q000633:toxicity*; D014764:Viral Proteins / Q000096:biosynthesis / Q000235:genetics
chemical_list: D009498:Neurotoxins; D014764:Viral Proteins; C492234:p35 protein, Baculovirus; D002945:Cisplatin